文献速递预防保健、筛查与疫苗慢病管理

提升中小型基层诊所心血管疾病预防服务

Improving Delivery of Cardiovascular Disease Preventive Services in Small-to-Medium Primary Care Practices.
PubMed 文献 · J Am Board Fam Med · 2022-09-12

EvidenceNOW 计划向 1278 家小型基层诊所提供外部支持干预,以改善心血管病预防质量指标。事件研究显示阿司匹林、血压、胆固醇和吸烟指标均有显著改善,但双重差分仅吸烟具统计显著性;结论认为干预可小幅提升预防质量指标。

要点

  • 外部支持干预可小幅提升基层诊所心血管预防质量指标。
  • 吸烟筛查与咨询改善幅度最大,事件研究为+7.33个百分点。
  • 双重差分仅吸烟指标具统计显著性,其余指标幅度相似但不显著。

核心结论

  • EvidenceNOW 合作组织改善了全美中小型基层诊所的心血管预防质量指标,估计改善幅度虽小但反映了大样本平均变化。

研究设计与样本

  • 7 个区域合作组织向 1278 家小型基层诊所提供实践促进、健康信息技术支持、绩效基准、学习协作和社区联系等外部支持干预。
  • 采用事件研究比较干预前后变化,并用双重差分设计与 688 家外部对照诊所比较。

主要发现

  • 基线平均结局从 61.5%(胆固醇)到 64.9%(阿司匹林)。
  • 事件研究中阿司匹林提高 3.39 个百分点(95%CI 0.61-6.17),血压提高 1.59 个百分点(95%CI 0.12-3.06)。
  • 事件研究中胆固醇提高 4.43 个百分点(95%CI 0.33-8.53),吸烟提高 7.33 个百分点(95%CI 4.70-9.96)。
  • 双重差分估计幅度相似,但仅吸烟指标具统计显著性;吸烟干预前趋势显著,平行趋势检验不显著。

关键数值与推荐

  • 结局指标为符合 CMS 指定 ABCS 指标条件的患者比例:缺血性血管病风险者用阿司匹林、高血压者血压达标、胆固醇升高/糖尿病/心血管风险增加者他汀处方、吸烟筛查与戒烟咨询。

临床怎么用

  • 基层诊所可借助实践促进、健康信息技术支持和学习协作等外部支持来改善心血管预防服务。
  • 吸烟筛查与戒烟咨询可能是外部支持干预中较易见效的环节。

局限性

  • 估计改善幅度较小;双重差分仅吸烟指标显著,其他指标统计效能可能不足;吸烟指标干预前趋势显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The EvidenceNOW initiative provided smaller primary care practices with external support interventions to implement quality improvement strategies focused on cardiovascular disease prevention. This manuscript reports effectiveness of EvidenceNOW interventions in improving quality metrics. METHODS: Seven regional Cooperatives delivered external support interventions (practice facilitation, health information technology support to assist with audit and feedback, performance benchmarking, learning collaboratives, and establishing community linkages) to 1278 smaller primary care practices. Outcomes included proportion of eligible patients meeting Centers for Medicaid and Medicare Services-specified ABCS metrics, that is, Aspirin for those at risk of ischemic vascular disease; achieving target Blood pressure among hypertensives; prescribing statin for those with elevated Cholesterol, diabetes, or increased cardiovascular disease risk; and screening for Smoking and providing cessation counseling. An event study compared prepost changes in outcomes among intervention practices and a difference-in-differences design compared intervention practices to 688 external comparison practices. RESULTS: Mean baseline outcomes ranged from 61.5% (cholesterol) to 64.9% (aspirin). In the event study, outcomes improved significantly (aspirin: +3.39 percentage points, 95% CI, 0.61-6.17; blood pressure: +1.59, 95% CI, 0.12-3.06; cholesterol: +4.43, 95% CI, 0.33-8.53; smoking: +7.33, 95% CI, 4.70-9.96). Difference-in-differences estimates were similar in magnitude but statistically significant for smoking alone. Preintervention trends were significant for smoking, but parallel-trends tests were not significant. CONCLUSIONS: EvidenceNOW Cooperatives improved cardiovascular prevention quality metrics among small and medium sized primary care practices across the US. While estimated improvements were small, they reflected average changes across a large and diverse sample of practices.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Balasubramanian BA, Lindner S, Marino M, et al. Improving Delivery of Cardiovascular Disease Preventive Services in Small-to-Medium Primary Care Practices. J Am Board Fam Med. 2022. PMID: 36096660. doi:10.3122/jabfm.2022.AP.220038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。